OriGene Antibodies in recent publications
A common polymorphism in the LDL receptor gene has multiple effects on LDL receptor function Hum. Mol. Genet., Apr 2013; 22: 1424 - 1431.
Excitotoxicity Upregulates SARM1 Protein Expression and Promotes Wallerian-Like Degeneration of Retinal Ganglion Cells and Their Axons Invest. Ophthalmol. Vis. Sci., Apr 2013; 54: 2771 - 2780.
Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX Nature 497, 122-126 doi:10.1038/nature12052
Natriuretic Peptide Receptor-3 Gene (NPR3): Nonsynonymous Polymorphism Results in Significant Reduction in Protein Expression Because of Accelerated Degradation Circ Cardiovasc Genet, Apr 2013; 6: 201 - 210.
View All Citations >>
Home All anti-PARK2 antibodies
Also for PARK2 (NM_013987)
Homo sapiens parkinson protein 2, E3 ubiquitin protein ligase (parkin) (PARK2), transcript variant 2
AR-JP; LPRS2; PDJ; PRKN
Reacts with an internal sequence of the human 52 kDa Parkin protein.
PBS and 0.02% Sodium Azide
IgG purified (
Protein A or G Sepharose)
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
The Parkin antibody was tested to pulldown endogenously expressed Parking in HIT-T15 cells (Lane 1, HIT-T15 cells; Lane 2, negative control) and transiently transfected Parkin in Hek cells (Lane 3, Hek cells; Lane 4, negative control). Amount of antibody used: 4ul (=4ug) Lysate of cells used: 1000 ug
The Parkin antibody was tested to detect Parkin levels in stable Hek cells expressing Parkin. Antibody dilutions: 1:250 and 1:1000 Hek cell lysate used: 50 ug (lanes 1 & 4): 100 ug (lanes 2 & 5); 200 ug (lanes 3 & 6).